Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001808805-25-000019
Filing Date
2025-03-04
Accepted
2025-03-04 16:51:29
Documents
4
Period of Report
2025-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741125080.html 4  
1 FORM 4 wk-form4_1741125080.xml 4 4276
2 EX-24 nautilusbiotechnology-fo.htm EX-24 5017
3 GRAPHIC nautilusbiotechnology-fo001.jpg GRAPHIC 247556
4 GRAPHIC nautilusbiotechnology-fo002.jpg GRAPHIC 43866
  Complete submission text file 0001808805-25-000019.txt   412506
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Issuer) CIK: 0001808805 (see all company filings)

EIN.: 981541723 | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O NAUTILUS BIOTECHNOLOGY, INC. 201 INDUSTRIAL RD. #310 SAN CARLOS CA 94070
Business Address
Sankar Subramanian (Reporting) CIK: 0001856744 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39434 | Film No.: 25705685